関連する実験動画

Updated: Sep 10, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

分子交響と治療効果:口腔がん治療におけるチロシンキナーゼ阻害剤とカンナビジオール

Zainab Saad Ghafil AlRaheem¹, Thao T Le¹, Ali Seyfoddin¹

¹School of Science, Faculty of Health and Environment Science, Auckland University of Technology, Auckland 1010, New Zealand.

Current issues in molecular biology

|August 27, 2025

まとめ

頭と首の状細胞がん (HNSCC) は依然として課題です. このレビューでは,皮膚成長因子受容体 (EGFR) 阻害剤とカンナビジオール (CBD) を,組み合わせ戦略を含む潜在的な標的療法として検討しています.

科学分野:

腫瘍学
薬理学について
分子生物学

背景:

口腔状細胞癌 (OSCC) を含む頭頸状細胞癌 (HNSCC) は,世界的な悪性腫瘍である.
現在の治療法は,HNSCC/ OSCC患者のアウトカムに限られた改善をもたらす.
Epidermal Growth Factor Receptor (EGFR) タイロシンキナーゼ阻害剤 (TKI) は,OSCCの標的治療法として有望ですが,臨床効果は懸念されています.

研究の目的:

HNSCCにおけるEGFR-TKIsとCBDの分子メカニズムをレビューする.
これらの標的薬の臨床的洞察と可能性を議論する.
HNSCC治療におけるEGFR-TKIsとCBDの組み合わせの影響を調査する.

主な方法:

分子機構の文献レビュー
OSCCにおけるEGFR-TKIsに関する臨床試験データの分析
CBDの抗がん効果に関する臨床前および臨床的証拠の要約
EGFR-TKIとCBDによって調節される信号経路の探索

主要な成果:

EGFR- TKIsはOSCCの主要な経路を標的とするが,臨床有効性の課題は依然として残っている.
カンナビジオール (CBD) は,アポトーシスおよび自己死誘導,および免疫調節を含む抗がん性を持っています.
CBDはHNSCCで頻繁に制御不能な信号経路を調節する.
EGFR-TKIsとCBDを組み合わせることで生じる潜在的な相乗効果については,さらなる調査が必要である.

結論:

EGFR-TKIsとCBDは,HNSCC/OSCCに対する有望な標的療法です.
分子機構を理解することは治療戦略の最適化に不可欠です
EGFR- TKIsとCBDを併用した治療は,HNSCC患者の臨床効果を向上させる可能性がある.

キーワード:

カンナビジオール (CBD)皮質成長因子受容体 (EGFR)頭と首の状細胞癌 (HNSCC)タイロシンキナーゼ阻害剤 (TKI)

さらに関連する動画

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

関連する概念動画

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...